About EnEvolv
EnEvolv is a company based in Boston (United States) founded in 2011 was acquired by Zymergen in March 2020.. EnEvolv has raised $1.79 million across 4 funding rounds from investors including Zymergen, National Science Foundation and America’s Seed Fund. The company has 607 employees as of December 31, 2021. EnEvolv operates in a competitive market with competitors including Senti Biosciences, Avidity Biosciences, Poseida Therapeutics, Univercells and Sutro Biopharma, among others.
- Headquarter Boston, United States
- Employees 607 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ginkgo Bioworks, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of EnEvolv
EnEvolv has successfully raised a total of $1.79M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $225 thousand completed in December 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Grant — $225,000
-
First Round
First Round
(01 Jul 2013)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2016 | Amount | Grant - EnEvolv | Valuation |
investors |
|
| Nov, 2014 | Amount | Grant - EnEvolv | Valuation |
investors |
|
| Feb, 2014 | Amount | Seed - EnEvolv | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in EnEvolv
EnEvolv has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Zymergen, National Science Foundation and America’s Seed Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund backed by the US Government
|
Founded Year | Domain | Location | |
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Founded Year | Domain | Location | |
|
Provider of microbe-based diversified farm inputs
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by EnEvolv
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - EnEvolv
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Enevolv Comparisons
Competitors of EnEvolv
EnEvolv operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Senti Biosciences, Avidity Biosciences, Poseida Therapeutics, Univercells and Sutro Biopharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cell-based therapies for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Enevolv
Frequently Asked Questions about EnEvolv
When was EnEvolv founded?
EnEvolv was founded in 2011 and raised its 1st funding round 2 years after it was founded.
Where is EnEvolv located?
EnEvolv is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Is EnEvolv a funded company?
EnEvolv is a funded company, having raised a total of $1.79M across 4 funding rounds to date. The company's 1st funding round was a Seed of $1.79M, raised on Jul 01, 2013.
How many employees does EnEvolv have?
As of Dec 31, 2021, the latest employee count at EnEvolv is 607.
What does EnEvolv do?
EnEvolv, The Genome Engineering Company, engineers and licenses microorganisms to produce chemicals enzymes and small molecules for a variety of industries including specialty chemicals, food, energy, personal care, and pharmaceuticals. The Companys proprietary platform is built on Multiplex Automated Genome Engineering (MAGE) technology, developed by EnEvolvs co-founders, George Church and Farren Isaacs at Harvard. EnEvolv collaborates with companies to engineer novel microorganisms and improve their existing strains to increase production yield and product quality.
Who are the top competitors of EnEvolv?
EnEvolv's top competitors include Sutro Biopharma, Avidity Biosciences and Antheia.
Who are EnEvolv's investors?
EnEvolv has 3 investors. Key investors include Zymergen, National Science Foundation, and America’s Seed Fund.